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Abstract 
Introduction 
Dialysis adequacy is traditionally measured by monthly blood urea sampling and 
calculating sessional Kt/Vurea. Modern dialysis machines can estimate clearances each 
session, so we wished to compare on-line measurements with standard Kt/Vurea. 
Methods 
Urea clearance was estimated by intermittent changes in effective ionic dialysance 
(EID) and by continuous ultra violet (UV) light absorption of spent during the mid-week 
dialysis session. Total body water was calculated by the Watson equation and measured 
by multifrequency bioimpedance. 
Results 
We compared Kt/Vurea measurements in 162 patients with on-line assessments; 38 by 
UV absorption, 124 by EID (50 Fresenius 4008, and 74 Fresenius 5008). All on-line 
measurements over estimated single pool Kt/Vurea (UV absorption mean bias 0.25 
±0.24, EID 4008H 0.25 ±0.21 and 5008H 0.20±0.25), p<0.001. However, there was no 
difference between dual pool Kt/V and UV absorbance (1.28±0.26 vs 1.29 ±0.27), or by 
EID with the 4008 (1.40±0.26 vs 1.46±0.33), although the EID 5008 over estimated 
clearance (1.39 ±0.27 vs 1.31 ±0.22), p<0.01. Similarly, with dual pool Kt/Vurea the mean 
bias for UV absorption was 0.08 ±0.35, IED 4008 0.13 ±0.55, and IED 5008 -0.2 ±0.36. 
Hence the mean bias was greater with the IED 5008 compared to UV absorption 
(0.08±0.35 vs -0.2 ±0.36 vs p<0.01), 
 
Conclusions 
On-line measurements allow dialysis adequacy to be measured every session. We found 
that although on-line clearances over  estimated single pool Kt/Vurea measurements, 
there were no significant differences between the continuous UV light absorbance 
method, and intermittent EID.  
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Introduction 
Dialysis dose is an important determinant of clinical outcomes for patients with 
End Stage Renal Disease (ESRD) treated by maintenance dialysis. The European Best 
Practice Clinical Guidelines recommend a minimum treatment dose, based on serum urea 
clearance, measured by equilibrated Kt/Vurea of 1.2 (K – urea dialyzer clearance, t 
sessional time, V volume of urea distribution) [1]. However, in routine clinical practice 
this value may not be achieved for every haemodialysis session in all patients [2,3]. 
Clinical guidelines, recommend that the dialysis dose should be measured by a validated 
method [1]. Apart from blood sample-based methods, alternative methods determining 
dialysis dose have been developed, mostly based on measurements of dialysate 
conductivity [4,5] or urea [6], and more recently using ultraviolet absorbance in the 
spent dialysate [7].These methods potentially allow quantitative assessment of dialysis 
clearance with every dialysis session. 
The dose of dialysis is traditionally defined as the amount of urea 
cleared/session. Current methods include the Urea Reduction Ratio (URR) which is a 
simple comparison of the pre- and post-dialytic serum urea concentrations. In contrast 
to other methods, the URR method does not take into account that urea is additionally 
removed from the blood by ultrafiltration. As such the greater the ultrafiltration 
volume removed during dialysis, the more inaccurate the results of dialysis dose 
calculation become based on URR [8,9]. As such most centres use Kt/Vurea, which 
incorporates ultrafiltrate urea losses [10-12]. There are several variations of the 
Kt/Vurea formula, depending upon whether urea distribution in the body is modelled as 
a single or dual pool, and whether Kt/Vurea reflects a single mid-week session, or is 
equilibrated, or averaged over a week to allow for comparison of less or more frequent 
dialysis treatment schedules [13]. 
Advances in dialysis machine technology have introduced automatic non-invasive 
online measurements designed as alternatives to the conventional blood sampling 
method, laboratory analysis, and calculation. These include intermittent assessments of 
clearance by measuring the effective ionic dialysance (EID) of dialysate sodium (Na+) 
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Diascan™, Baxter Health Care, Deerfield, USA, and Online Clearance Monitoring 
(OCM™) and Online Clearance (OLC™) Fresenius Medical Care, Bad Homberg, Germany), 
and continuous methods based on ultraviolet light (UV) optical sensors measuring 
absorbance, using C band: 280 nm -100 nm light emitting diodes, in spent dialysate 
(Adimea™ B. Braun, Hessen, Germany, and Dialysis Dose Monitor™, Nikkiso, Tokyo, 
Japan). Although, UV absorbance of the spent dialysate is not specific for urea [14]. 
Castellarnau and colleagues reported a correlation of 0.93 between blood based 
Kt/Vurea and AdimeaTM measured clearance in a study of 64 subjects [7]. Sodium ions 
represent the largest proportion of freely mobile charged electrolytes in the dialysate 
and their concentration predominantly determines the total conductivity. Although the 
smaller, positively-charged sodium ions differ from the larger non-charged urea 
molecule, both particles exhibit comparable in-vitro and in-vivo diffusion 
characteristics across synthetic dialysis membranes, as their specific diffusion 
coefficient is almost identical at 37°C (Na+: 1.94 x 10 – 5 cm2/s, Urea: 2.20 x 10 – 5 
cm2/s [15,16]. Under real dialysis conditions, the difference in clearance is even smaller 
than the difference of diffusion coefficients, as the clearance is limited by blood and 
dialysate flow rates and not by the diffusion process across the dialyser membrane. By 
means of indirect determination of ion concentrations in the dialysate (measurement of 
conductivity at the inflow and outflow of the dialyser) it is technically possible to 
determine the diffusion profile of sodium ions across the dialysis membrane and thus 
estimate the dialysance or ionic clearance (D). On the basis of the dialysance of sodium 
ions, the “diffusibility” of urea through the membrane (permeability) and thus urea 
clearance can be estimated [16,17]. In order to achieve a detectable diffusion of 
sodium ions across the membrane, then the diffusion gradient of sodium between the 
blood and dialysate fluid must be temporarily increased. For this purpose, the dialysis 
machine induces a short term pulse to increase (or decrease) the sodium concentration 
in the dialysate, thereby resulting in an increase in diffusion of sodium ions into the 
blood compartment or in the reverse direction [18]. Assuming that the conductivity 
pulse does not exceed the specified conductivity limits, alternate pulses increase and 
decrease conductivity to ensure that the sodium balance remains as neutral as possible 
[19]. 
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 It has been suggested that with the advances in dialysis machine technology 
then on-line clearance could replace traditional pre- and post-dialysis blood sampling to 
estimate diallyzer urea clearance. As there have been no studies comparing traditional 
blood based Kt/Vurea measurements of dialysis clearance and both the continuous UV 
absorbance method and intermittent EID methods we evaluated our own data. 
 
Materials and Methods 
We retrospectively audited measurements of dialysis session urea clearance 
measured by traditional blood based methods in adult haemodialysis patients attending 
for routine mid-week assessments of outpatient dialysis treatments. To be included in 
the audit patients had to have contemperaneous pre- and post-dialysis session 
bioimpedance measurements and on-line clearance, in addition to pre- and post-
sessional serum sampling. 162 patients fulfilled all of these criteria. The audit reviewed 
dialysis sessions in separate dialysis centres in July and November 2016. 
Serum urea, other biochemistries were measured in a UK accredited 
laboratory (External Quality Assurance (EQA) ISO/IEC 17043) using an automated 
analyser (Roche Cobas, Roche Diagnostics, Maidenhead, UK), with the post-dialysis 
samples taken using the slow-flow method [1,10]. Sessional Kt/Vurea was calculated by 
both single and dual pool methods (appendix) [1,10]. We also recorded assessments of 
on-line clearance either using continuous UV absorbance method (BBraun DialogueR+, 
(BBraun Avitum AG, Melsungen, Germany) or by the intermittent EID method 
(Fresenius 4008H and 5008H, Fresenius Medical company AG, Bad Homberg, Germany). 
All patients used high flux dialysers (Elisio series, Nipro, Osaka, Japan) [20], and were 
anticoagulated with a single bolus dose of tinzaparin (Leo Laboratories, Prices 
Risborough, UK), median dose 2500 (2500-2500) IU [21]. Dialysate water met 
ultrapure standards and temperature was cooled to 35-35.5oC. Dialysate biochemistry; 
sodium 138 (136-138), potassium 2.0 (1.0-2.0) mmol/L, calcium 1.25 (1.0-1.35) mmol/L, 
bicarbonate, acetate and magnesium concentrations were set at 32, 3.0 and 0.5 mmol/L, 
respectively, Patients were allowed one drink (180 mL) during dialysis and actively 
discouraged from eating during dialysis sessions. We excluded any patient who became 
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symptomatically hypotensive during the dialysis session requiring a reduction in 
ultrafiltration rate  or given intra-venous fluids. 
Patients had standing height measured and weighed pre-and post-dialysis. Urea 
volume was estimated using the Watson formula (appendix) [18], and by multifrequency 
bio-impedance (InBody S10, Seoul, South Korea) [22,23]. Patients with amputations, 
paralysed limbs, pacemakers or other implantable cardiac devices were excluded. 
 
Statistical analysis 
 
Results are expressed as mean ± standard deviation, or median and interquartile 
range, or percentage. We used standard statistical analysis D'Agostino & Pearson 
normality test, t test, Mann Whitney U test, anova or Kruskal Wallis were used for 
parametric and nonparametric data respectively, with appropriate correction for 
multiple analyses where appropriate, and Chi square testing with correction for small 
numbers, with Spearman correlation used for non-parametric data. Statistical analysis 
was performed using Graph Pad Prism (version 7.0, Graph Pad, San Diego, CA, USA) and 
Statistical Package for Social Science version 24.0 (IBM Corporation, Armonk, New 
York, USA) and Analyse-It (Analyse IT 4.0, Leeds, UK) for Bland Altman analysis. 
Statistical significance was taken at or below the 5% level. 
 
Ethics 
This retrospective audit complied with NHS guidelines (UK NHS guidelines for 
clinical audit and service development). In keeping with the Hospital Trust policy no 
patient identifiable data was used. 
 
Results 
We reviewed the results from 162 patients, who had paired sessional Kt/Vurea 
and on-line clearance measurements. Their mean age was 68.0±14.1 years, 58% were 
male (94); 75 (46.3%) diabetic, white ethnicity 78 (48%), black: 31 (19%), asian 47 
(29.3%) and other races 6 (3.7%). There were no differences in patient demographics, 
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percentage of diabetics or body composition between the groups (Table 1). Similarly, 
there were no differences in standard pre-dialysis blood testing. On-line clearance was 
greatest with EID with the 4008 dialysis machine and least with UV light absorbance 
with the BBraun Dialogue R+ (table 1). 
There was a correlation between single pool Kt/Vurea using the Watson equation 
and on-line clearance for all machines; BBraun Dialogue R+ r2=0.40, Fresenius 4008H 
r2=0.62, and Fresenius 5008H r2=0.31, all p<0.001. For all machines the single pool 
Kt/Vurea using the Watson formula was greater than on-line clearance (all p<0.001). 
The mean bias between Kt/Vurea and on-line clearance was similar for all three dialysis 
machines; BBraun Dialogue R+ 0.25 ±0.24, and Fresenius 4008H 0.25 ±0.21 and the 
Fresenius 5008H 0.20±0.25 (Figures 1-3). 
Total body water was also measured by bioimpedance, and single pool Kt/Vurea, 
using bioimpedance measured total body water, was greater for all dialysis machines 
when compared to the on-line clearance (Table 1). We noted that the difference in 
single pool Kt/Vurea between bioimpedance and Watson formula was greater for 
smaller patients and less for larger patients (Figure 4). There was a correlation 
between single pool Kt/Vurea using bioimpedance total body water and on-line clearance 
for all machines; BBraun Dialogue R+ r2=0.21, p=0.003; Fresenius 4008H r2=0.34, 
p=0.001; and Fresenius 5008H r2=0.12, all p=0.002. 
We then calculated dual pool Kt/Vurea, and using the Adimea™ the UV 
absorbance method was not different to Kt/Vurea clearance, mean bias 0.014 ±0.237, 
p>0.05, r2 =0.36, nor was the EID method when using the 4008 dialysis machine, mean 
bias 0.055 ±0.677, p>0.05, r2 =0.60, but mean bias was significantly greater with the 
EID and the 5008 dialysis machine, 0.08 ±0.23, p <0.01. In addition, bias appeared to 
increase with increasing clearance. For all machines single pool Kt/Vurea was greater 
compared to dual pool calculated Kt/Vurea using the Watson formula, (all p<0.001). 
When using a dual pool Kt/Vurea model then the mean bias for UV absorption was 0.08 
±0.35, IED 4008 0.13 ±0.55, and IED 5008 -0.2 ±0.36. As such, the mean bias was 
greater with the IED 5008 compared to Adimea™ (0.08±0.35 vs -0.2 ±0.36 vs p<0.01), 
8 
 
but not with 4008 machines. As with total body water measured by Watson formula, 
the degree of bias increased with the 5008 with increasing total body water. 
Although there was no difference in the pre-dialysis serum sodium, when we 
compared the relative change in pre minus post serum sodium, the difference was 
significantly different using the BBraun DialogueR+ machines compared to the 
Fresenius 4008 and 5008 machines, -2 (-4 to 0) vs 0 (-2 to 2) and 1.0 (-1.8 to 3.0) 
mmol/L, p<0.001, respectively,despite similar changes in pre- to post-dialyhsis weight. 
 
Discussion 
The National Co-operative study (NCDS) established the importance of urea 
clearance by haemodialysis in determining patient outcomes [24], and Frank Gotch 
subsequently suggested a sessional Kt/Vurea cut off to determine dialysis adequacy 
[25]. The NCDS measured urea post-dialysis and then pre- and post-the following 
dialysis session to establish a time averaged urea concentration. Gotch simplified this 
to two blood samples, pre- and post-the midweek dialysis session. Errors in calculating 
Kt/Vurea can be introduced by not compensating for the rebound in serum urea post-
dialysis [8], and as such clinical guidelines advise on standardised methods to take the 
post-dialysis sample [1,10]. Advances in dialysis machine technology have led to the 
development of on-line clearance monitors. Indeed, in some countries, the practice has 
changed from measuring Kt/Vurea by monthly blood testing to using the on-line 
clearance for each dialysis session, and dispensing with blood testing [26].   
We therefore wished to review the results obtained with two different methods 
of estimating on-line clearance and standard methods of calculating Kt/Vurea. Previous 
validation studies have reported that the second generation Daugirdas’ formula has a 
total error in an acceptable range of ≤ 5% for sessional Kt/Vurea between 0.7 and 2.1 
[13]. The EID method measures clearance intermittently, and indirectly by inducing an 
increased sodium gradient between the serum and dialysate and then measuring the 
change in dialysate conductivity [4,5], whereas the other method used continuous 
monitoring of the dialysate effluent by UV light [7,14]. We found that both OCM™ and 
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ADMEA™ over estimated urea clearance compared to single pool Kt/Vurea. A previous 
study based on 10 patients using the OCM™ with a 4008 dialysis machine, reported 
that the OCM™ underestimated spKt/Vurea using the Watson equation but provided 
similar results when using bioimpedance measurements [27,28]. As with previous 
studies, we found that anthropomorphic estimates of total body water differed 
compared to bioimpedance [27], and such generally resulted in a lower Kt/Vurea value. 
In particular we found that total body water measured by bioimpedance was greater 
than that derived from the Watson formula for smaller patients, whereas total body 
water was greater with the Watson equation for heavier patients, in keeping with 
previous reports [29]. As such, depending upon the size distribution and body 
composition of patients, the results of studies will vary [30]. 
An early study on 10 patients suggested an error of around 9% between OCM™ 
clearance and the Daugirdas second generation spKt/Vurea [4,13], and that the main 
cause of error was due to estimates of body water [19]. Similarly, another small study 
reported a 6% difference [5], and a further small based on 10 patients reported that 
ionic clearance using the OCMTM reported a similar urea clearance when bioimpedance 
measurements of total body water were used, but not when total body water estimated 
by the Watson equation were used [28]. Differences between these earlier smaller 
studies, may be due to differences in the patient population studied and between 
dialysis practices, in particular whether patients were allowed to eat or drink during 
treatment sessions, and also potentially by differences in dialysate temperature. 
Previous studies using continuous UV absorbance measurements of waste dialysate 
UV have reported differing results, with reports that this method underestimates urea 
clearance compared to spKt/Vurea [14], both over and under estimated urea clearances 
[7], and yet others showing similar results for both UV absorbance and EID methods 
[14]. We found similar bias between measured spKt/Vurea and both UV absorbance and 
EID methods. However, when we compared on-line clearances with dual pool Kt/Vurea, 
there were no significant differences with either the UV absorbance or EID on the 
4008 dialysis machines, although the EID method gave higher clearances with the 
5008. Previous studies have shown that differences in total body water affect 
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estimates of clearance with the EID method [4,5,16,17,19], and this is shown by the 
differences between on-line clearance estimates when using Watson and bioimpedance 
derived total body water. 
As the EID-based methods determine on-line clearance “at predefined or 
programmed intervals, they could potentially over estimate clearance if blood for 
dialysate flows dropped during the time period between measurements. In our study we 
excluded patients who had symptomatic hypotension and either had a reduction in 
ultrafiltration rate or given intra-venous fluids, and so did not observe any major 
changes in patient cardiovascular stability, and as such did not note any significant 
difference in the bias between EID or UV absorbance methods and Kt/Vurea, although 
dialysis clearance was estimated to be greater by EID. 
In addition, as EID relies on a change in sodium gradient, it has been estimated 
that for each measurement the patient receives a small net influx of sodium (1.53+/-
7.62 mmol) [4]. As such, the pulsed change in sodium gradient induced between blood 
and dialysate should alternate to prevent any sodium loading during dialysis. We did 
find a difference in the change in post-dialysis serum sodium concentrations compared 
to pre-dialysis concentrations when using an indirect selective electrode method [31]. 
As we made no formal sodium balance study it is unclear whether the differences 
observed in pre- and post-dialysis measurements could be due to any additional sodium 
administered during the EID measurements. The Fresenius dialysis machines allow for 
different frequency of measurements, and previous studies have not specified the 
number of measurements made, and our centre uses the shortest time interval setting, 
which may have led to more measurements than previous reports. On the other hand, 
EID by monitoring dialysate sodium in fresh and waste dialysate, potentially offers an 
estimation of sodium removal during a dialysis session, and could be used to ensure no 
net sodium gains.  
As with any study, the results must be taken in context, in that urea clearance 
during a dialysis session can be affected by many factors, including dialyser type, 
effective treatment time, blood and dialysate flows, dialysate composition both 
vascular access type and access recirculation, and cardiac output, and as such our 
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results may differ from those in other centres with different practices. In addition, 
our centre uses cooled dialysates, and lower dialysate sodium concentrations [32], 
compared to many others, and whether this may influence the IED method remains to 
be determined.Although, we found that both methods over-estimated clearance 
compared to spKt/Vurea clearances, and both under-estimated clearance compared to 
dual pool Kt/Vurea, on-line clearance measurements complement standard blood testing. 
As prospective studies have failed to demonstrate a survival benefit for achieving a 
higher sessional Kt/Vurea target [31], then the ability to make a relative comparison 
between on-line clearances and standard blood testing to assess dialysis urea clearance 
with each dialysis session, rather [33] han absolute values of on-line clearance 
measurements may be more important in clinical practice. 
The requirement for monthly blood tests to determine HD adequacy is a 
compromise between cost and the utility of the measurement, but risks patients 
receiving reduced clearances. Whereas on-line clearance allows the delivery of the 
dialysis dose to be monitored during every dialysis session, and if necessary 
modifications can be made during the dialysis session. As such on-line clearances 
provide a practical instrument for regular clinical use and complement other formulas 
for estimating dialysis urea clearances. 
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Appendix 
 
Watson formula for total body water 
Men 
Total body water = 2.447 - (0.09156 x age) + (0.1074 x height) + (0.3362 x weight) 
Women 
Total body water  = -2.097 + (0.1069 x height) + (0.2466 x weight 
 
Second generation Single pool variable volume Kt/Vurea (Daugirdas) 
 
Kt/Vurea = - log (Post BUN/preBUN -0.3) + (4-3.5 x Post BUN/preBUN) x 
ultrafiltration/post dialysis weight  
 
Blood urea nitrogen (BUN) mg/dL 
 
Dual pool (equilibrated) Kt/Vurea 
Equilibrated Kt/Vurea = Single pool Kt/Vurea – 0.6 * (Single pool Kt/Vurea)/t + 0.03 
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Figure 1. Bland Altman plot of the average dialysis session clearance and the difference 
between BBraun DialogueR+ on-line clearance and single pool Kt/Vurea using the Watson 
formula for total body water. Mean bias 0.25 (solid line) and 95% limits of agreement  
-0.13 to 0.56 (dotted lines) 
 
Figure 2. Bland Altman plot of the average dialysis session clearance and the difference 
between Fresenius 4008H on-line clearance and single pool Kt/Vurea using the Watson 
formula for total body water. Mean bias 0.25 (solid line) and 95% limits of agreement  
-0.13 to 0.62 (dotted lines) 
 
Figure 3. Bland Altman plot of the average dialysis session clearance and the difference 
between Fresenius 5008H on-line clearance and single pool Kt/Vurea using the Watson 
formula for total body water. Mean bias 0.20 (solid line) and 95% limits of agreement  
-0.23 to 0.65 (dotted lines) 
 
Figure 4. Difference between bioimpedance and Watson formula derived single pool 
Kt/Vurea and mean bioimpedance and Watson formula total body water. Univariate 
analysis r= -0.19, p=0.017 
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Table 1. Patient demographics, body composition and pre-dialysis blood tests in patients 
dialysing with BBraun DialogueR+, Fresenius 4008H and 5008H. Results expressed as 
integer, percentage, mean ±standard deviation. *p<0.05,** p<0.01, **p<0.001 vs BBraun 
DialogueR+ 
 
 BBraun Dialogue Fresenius  
  4008 
Fresenius 
  5008 
 
Number of patients 
 
38 50 74 
 
Gender Male (%) 
 
 
21(55.2%) 
 
27 (54%) 
 
46 (62%) 
 
Age years 
 
71.7 ±13.0 
 
 
65.5 ±12.6 
 
67.7±15.3 
 
Diabetic (%) 
 
22 (61) 
 
 
20 (40) 
 
 
41 (55.4) 
 
 
Weight pre-dialysis kg 
 
71.3 ± 20.9 
 
 
72.7 ± 20.3 
 
72.7 ± 16.9 
 
Weight post-dialysis kg 
 
 
69.4  ± 20.7 
 
 
71.1±   20.0 
 
 
71.1 ± 16.6 
 
Body mass index 
kg/m2 
 
25.3 ±  6.8 
 
 
26.6 ± 7.1 
 
26.7 ±  5.9 
 
Fat mass kg 
 
22.8 ± 14.6 
 
 
23.1 ±   12.6 
 
21.8 ±  12.9 
Pre-dialysis serum urea 
mmol/L 
 
16.8  ± 6.1 
 
 
19.0  ± 5.4 
 
 
18.7 ± 6.4 
 
Pre-dialysis haemoglobin g/dL 
 
 
10.4 ± 1.4 
 
 
11.0  ± 1.4 
 
11.2  ± 1.1 
Pre-dialysis albumin 
mmol/L 
 
Re dialysis serum sodium              
mmol/L 
 
34.8 ±   6.7 
 
138 ±3.6 
 
 
39.8  ±  3.5 
 
139 ±3.4 
 
38.6  ± 4.7 
 
138 ±3.3 
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On-line clearance 
Kt/V 
 
1.29  ± 0.27 
 
 
1.46 ± 0..33* 
 
1.39  ± 0.27 
Single pool Kt/Vurea (Watson 
total body water) 
 
1.54 ± 0.29 
 
 
1.71   ± 0.30*** 
 
 
1.59 ± 0.26 
 
Single pool Kt/Vurea 
(Bioimpedance total body water) 
 
1.71 ± 0.27 
 
 
1.99 ±  0.47*** 
 
 
1.75 ± 0.40 
 
DualpoolKt/Vurea (Watson total 
body water) 
 
1.28 ± 0.26 
 
1.40  .026* 
 
1.31 ±  .022 
 
Dual pool Kt/V (bioimpedance 
total body water) 
 
1.37 ± 0.40 
 
1.54 ±0.49 
 
1.51 ±0.4 
 
